Eloxx Pharmaceuticals, Inc. (ELOX) stock
ELOXNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 16, 2026Score 7/30
$10.41−1.33 (-11.33%)
Close on Nov 18, 2026Market cap $70.68MP/E –Yield –
Eloxx Pharmaceuticals price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Eloxx Pharmaceuticals's price to book ratio was 1.1× on Nov 11, 2026, against 24.5× a year earlier. Over the last 5 years it ranged from 1.1× to 382.7×, with a median of 57.0×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 1.1× | −8.0 |
| 2023 | Jul 31, 2023 | 9.1× | −66.7 |
| 2022 | Oct 31, 2022 | 75.9× | +55.4 |
| 2021 | Dec 31, 2021 | 20.4× | −96.2 |
| 2020 | Dec 31, 2020 | 116.6× | +45.0 |
| 2019 | Dec 31, 2019 | 71.6× | −18.6 |
| 2018 | Dec 31, 2018 | 90.2× | −305.3 |
| 2017 | Dec 29, 2017 | 395.5× | – |
See a number that looks wrong?